|Articles|March 9, 2023
Genetic Insights for Biopharmaceuticals: Propelling Drug Candidates Into Therapeutic Assets (Mar 2023)
Author(s)Thermo Fisher
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
Retatrutide Delivers Up to 22.6% Weight Loss in Two New Phase III Trials
5